| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| R&D Expense | $456K | +89.8% |
| Operating Income | -$6.4M | -130.3% |
| Interest Expense | $60K | +238.1% |
| Pre-tax Income | -$5.6M | -93.7% |
| Net Income | -$5.6M | -93.7% |
| EPS (Diluted) | -$0.22 | -46.7% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Current Assets | $46K | +111.4% |
| Total Assets | $46K | +28.8% |
| Current Liabilities | $1.4M | -22.4% |
| Long-term Debt | $20K | -97.8% |
| Total Liabilities | $1.4M | -22.4% |
| Stockholders' Equity | -$1.3M | +23.4% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$556K | +43.0% |
| Financing Cash Flow | $593K | -36.4% |